|
|
||||||||
EDITORIAL |
Requests for reprints should be sent to Jeffrey Levi, PhD, Center for Health Services Research and Policy, George Washington University Medical Center, 2021 K St, NW, Suite 800, Washington, DC 20006 (e-mail: jlevi{at}gwu.edu).
| INTRODUCTION |
|---|
|
|
|---|
Just over 20 years into the epidemic, we have learned much about HIV, how it is transmitted, who is potentially at risk, and how HIV infection might be treated. This progress has been made even as our knowledge base has shifted and expanded. We have learned to define (if not always adopt) sound public health strategies and policies based on the science as we know it. And we have not been afraid to adapt our approaches as our scientific knowledge evolvesfor example, attitudes toward early HIV testing and early HIV treatment have changed as our understanding of behavioral and treatment interventions has changed.
That said, hubris would be inappropriate. As we begin the third decade of the epidemic, we still have far to go. In some respects, as much as we have learned about HIV, we have not succeeded on some very basic frontsmost important, in the core public health functions of ensuring that people learn their HIV status, reduce their risky behaviors, and have access to new treatments that might prolong life.
| THE PROBLEM OF LATE DIAGNOSIS |
|---|
|
|
|---|
These dismal findings are evidence not only that people infected with HIV are in some way disconnected from the health care delivery system, as indeed many are, but also that those who are in the system are not getting properly screened or are not getting access to needed care. For example, among persons reported with HIV/AIDS for whom payer status was known, 22% were receiving Medicaid at the time of their diagnosisthat is, they were in a care system, one that will pay for HIV testing. Even so, 48% of those diagnosed with HIV and receiving Medicaid were diagnosed with AIDS within 1 year after being tested for HIV. Those with private insurance fared worse: 52% of their diagnoses were late.3
These studies suggest that even when individuals present to the health care system with conditions that suggest high risk for HIV infection, they are not necessarily being offered testing in a systematic way. A 1997 study at one public hospital found that 62% of inpatients with newly diagnosed AIDS had previously received inpatient or outpatient medical care from that hospital, with a mean of 4 encounters over the previous 12 months, frequently for conditions that should have signaled a need for HIV testing before the test was ultimately given.4 The good news is that subsequent interventions at that hospital increased outpatient HIV testing.5
| THE IMPORTANCE OF BEING TESTED |
|---|
|
|
|---|
Evidence exists that knowledge of one's serostatus, in addition to being the first step toward receiving appropriate treatment, also promotes preventionoriented behavior. In a CDC study of 180 persons with recently acquired HIV infection, 90% reported adopting some change in sexual behavior after learning their HIV serostatus, including 60% who used condoms more often and 49% who said they had sex less often. Another very important finding from this small survey was that those who were receiving health care for HIV infection were more likely to report changing their sexual behavior (93%) than were those not receiving care (81%).7
These data and many of the HIV-related articles in this issue suggest several research and policy questions that the public health community must address in the third decade of the epidemic.
| KEY RESEARCH AND POLICY QUESTIONS |
|---|
|
|
|---|
How do we address HIV-related stigma, which affects both the competence of providers to address HIV risk behaviors, prevention services, and treatment and the willingness of those with HIV or at risk for HIV infection to seek out these services? Herek et al.10 and Valdiserri11 both suggest that homophobia, among other factors, remains a major impediment to successful prevention interventions. External homophobia creates fear of seeking out services and may make those services culturally inappropriate. (This is also true for other "phobias" associated with HIV, including attitudes toward substance users and toward heterosexuals who are sexually active outside marriage.) But the internalized homophobia Valdiserri references, which can mediate risky behavior on the part of men who have sex with men, may well be more detrimental to the prevention effort.
This is an area where only limited research has been undertaken. How does public health take on the issue of homophobia, not just to alter the behavior of society in general by destigmatizing homosexuality, but to undertake interventions at the community level among gay, lesbian, bisexual, and transgendered persons that will be effective in helping them overcome the internalization of this stigmatization?
The overwhelming response to the Journal's June 2001 issue on lesbian, gay, bisexual, and transgender health demonstrates the demand for good data on this issue. The level of research needed can be achieved only with an investment of resources from the federal government through the National Institutes of Health and the CDC. We now have overwhelming data to support the need for such research for public health, not political, reasons. It is time for those agencies to act forcefully on this issue as a public health problem.
How do we hold the health care delivery system accountable for better adherence to identification strategies for those at risk for HIV infection and consistent adherence to care regimens? Arno's brief on using an index of Pneumocystis carinii pneumonia to measure performance of health systems is one step in that direction.12 But much more needs to be done toward public health's having the lead in defining the appropriate standard of care for the health care delivery system.
The job starts within the Department of Health and Human Services, which recently chose to remove from a proposed regulation of Medicaid managed care plans a requirement that these plans follow the department's own HIV anti-retroviral treatment guidelines.13 With that requirement removed, Medicaid beneficiaries will have no guarantee of consistency of treatment across Medicaid managed care plansa challenge for the individual patient but also an issue of great public health importance, because inconsistent treatment approaches may promote the development of a drugresistant virus. It is important to remember in this context that Medicaid officials estimate that more than half of people living with HIV/AIDS in the United States have their care financed by Medicaid.14
It is our hope that future issues of the Journal can be a forum for discussion of research and commentary on these issues.
| Acknowledgments |
|---|
Accepted for publication November 5, 2001.
| References |
|---|
|
|
|---|
2. Campsmith M, Burgess D. Race/ethnicity and gender differences in late HIV testingresults from a supplemental HIV/AIDS surveillance project. Paper presented at: National HIV Prevention Conference; August 1215, 2001; Atlanta, Ga. Abstract 540.
3. Levi J, Kates J, Neal J, Gallagher K. Targeting HIV prevention services for people with HIV and at risk for HIV based on care financing mechanism. Paper presented at: National HIV Prevention Conference; August 1215, 2001; Atlanta, Ga. Abstract 471.
4. Alexander L, Sattah M, Ziemer DB, Del Rio C. Missed opportunities for HIV diagnosis at an inner city hospital in the United States. Paper presented at: XII International Conference on AIDS; June 28July 3, 1998; Geneva, Switzerland. Abstract 43141.
5. Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent-care clinicAtlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep.2001;50:538541.[Medline]
6. Centers for Disease Control and Prevention. HIV testing among populations at high risk for HIV infectionnine states, November 1995December 1996. MMWR Morb Mortal Wkly Rep.1998:47:10851091.[Medline]
7. Centers for Disease Control and Prevention. Adoption of protective behaviors among persons with recent HIV infection and diagnosisAlabama, New Jersey, and Tennessee, 19971998. MMWR Morb Mortal Wkly Rep.2000; 49:512515.[Medline]
8. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health.2001;91:10191024.[Abstract]
9.
Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health.2002;92:388394.
10.
Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 19911999. Am J Public Health.2002;92:371377.
11.
Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health.2002;92:341342.
12.
Arno PS, Gourevitch MN, Drucker E, et al. Analysis of a Population-Based Pneumocystis carinii Pneumonia Index as an Outcome Measure of Access and Quality of Care for the Treatment of HIV Disease. Am J Public Health.2002;92:395398.
13. Rosenbaum S, Sonosky C. An analysis of the Bush administration's proposed Medicaid managed care regulations. Center for Health Services Research and Policy, George Washington University School of Public Health, September 2001. Available (in PDF format) at: http://www.gwhealthpolicy.org/downloads/nprm_analysis.pdf. Accessed December 31, 2001.
14. Kaiser Family Foundation. Medicaid's role for persons with HIV/AIDS, October 2000. Available (in PDF format) at: http://www.kff.org/content/2000/1588/Mcaidhivfs.PDF. Accessed December 31, 2001.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |